Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High-throughput Omic Technology for Identification of Biomarkers of Relapsing Acute Disseminated Encephalomyelitis in the Immune Cell Network

NCT06863974 is registered in ClinicalTrials.gov with University Hospital, Angers as lead sponsor.

NCT NCT06863974
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06863974 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High-throughput Omic Technology for Identification of Biomarkers of Relapsing Acute Disseminated Encephalomyelitis in the Immune Cell Network
Lead sponsor
University Hospital, Angers
Phase
Not applicable
Overall status
Recruiting
Start date
November 16, 2025
Completion date
February 1, 2030
Enrollment
20 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

acute disseminated encephalomyelitis, encephalitis autoimmune